Beyond Weight Loss: The Billion-Dollar Business of Treating 'Ozempic Face'

Key points

• The rise of GLP-1 drugs like Ozempic has created a multi-billion dollar "corrective economy" for aesthetic treatments to address facial volume loss.
• Dermatologists are using fillers, biostimulators, and energy devices to treat "Ozempic face," with costs ranging from thousands to tens of thousands of dollars.
• The success of pharmaceutical giants is now directly fueling growth for companies in the medical aesthetics sector.
• This trend highlights a shift in consumer spending, where money saved on food may be reallocated to cosmetic procedures.
• For the food industry, GLP-1s represent a long-term challenge, necessitating a pivot towards lower-calorie and high-satiety products.

This report is part of Foodie Pundit premium coverage. Foodie Pundit members read the full story. See membership.

Sources and methodology

Reported from the public datasets below.

• Bureau of Labor Statistics (BLS) - Consumer Price Index, food away from home
• Federal Reserve Economic Data (FRED) - Food services and drinking places series
• U.S. Census Bureau - Monthly Retail Trade, food services

All sources Foodie Pundit reports from

More from the Foodie Pundit Newsroom

• New York's $32 One-Item Sandwich Gamble
• The Unkillable American Steakhouse
• The Secret Drug Problem In The Dairy Aisle
• Undeclared Coconut In Whole Foods Macadamia Nuts Triggers Nationwide Recall, Highlighting Systemic Allergen Risks
• McDonald's Great Pie Swap Has A Gooey New Winner